- Report
- May 2024
- 140 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1188EUR$1,250USD£998GBP
- Report
- May 2023
- 80 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2022
- 68 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2022
- 62 Pages
Global
From €1901EUR$2,000USD£1,597GBP
Optic Neuropathy Drug is a type of drug used to treat optic neuropathy, a condition that affects the optic nerve and can lead to vision loss. These drugs are used to reduce inflammation and improve nerve function. They are typically prescribed for patients with optic neuropathy caused by diabetes, multiple sclerosis, or other conditions. Commonly used drugs include corticosteroids, immunosuppressants, and antivirals.
Optic Neuropathy Drugs are part of the larger Central Nervous System Drugs market, which includes drugs used to treat a variety of neurological conditions. These drugs are used to treat conditions such as Alzheimer's disease, Parkinson's disease, epilepsy, and multiple sclerosis.
Some companies in the Optic Neuropathy Drug market include Novartis, Pfizer, Merck, and Sanofi. Show Less Read more